| Companies sponsors |
Novo Nordisk (insulin icodec) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Black Health Agency for Equality |
| |
Diabetes Research and Wellness Foundation |
| |
Diabetes UK |
| |
Haemochromatosis UK |
| |
InDependent Diabetes Trust |
| |
Network of Sikh Organisations |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| Professional groups |
Association for the Study of Obesity |
| |
Association of British Clinical Diabetologists |
| |
British & Irish Hypertension Society |
| |
British Association for Nursing in Cardiovascular Care |
| |
British Geriatrics Society |
| |
British Heart Foundation |
| |
Primary Care Diabetes Society |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society for Endocrinology |
| |
TREND Diabetes |
| |
UK Clinical Pharmacy Association |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
A. Menarini Farmaceutica Internazionale (canagliflozin, metformin) |
| |
AstraZeneca (exenatide, dapagliflozin, metformin, saxagliptin) |
| |
Aurobindo Pharma (gliclazide, metformin, sitagliptin, vildagliptin) |
| |
Bioproject (glibenclamide) |
| |
Boehringer Ingelheim (empagliflozin, linagliptin, metformin) |
| |
Bristol laboratories (gliclazide) |
| |
Brown and Burk UK (gliclazide, glimepiride, metformin, pioglitazone) |
| |
Celix Pharma (metformin, sitagliptin) |
| |
Colonis Pharma (metformin) |
| |
Dr Reddy’s Laboratories (metformin, sitagliptin) |
| |
Eli Lilly (dulaglutide, insulin, tirzepatide) |
| |
Flamingo Pharma (gliclazide) |
| |
Genus Pharmaceuticals (metformin, sitagliptin) |
| |
Glenmark Pharmaceuticals (metformin, sitagliptin) |
| |
Ipca Laboratories (metformin) |
| |
Krka UK (gliclazide, sitagliptin) |
| |
Lupin Healthcare (gliclazide) |
| |
Morningside Healthcare (metformin) |
| |
MSD (ertugliflozin, metformin, sitagliptin) |
| |
Mylan (gliclazide, insulin, pioglitazone, sitagliptin) |
| |
Neon Healthcare (metformin, pioglitazone) |
| |
Novartis (metformin, vildagliptin) |
| |
Novo Nordisk (insulin, liraglutide, semaglutide) |
| |
Pfizer (glipizide) |
| |
Pinewood Healthcare (metformin) |
| |
Rosemont Pharmaceuticals (metformin) |
| |
Sandoz (metformin, pioglitazone) |
| |
Sanofi (insulin, lixisenatide) |
| |
Servier Laboratories (gliclazide) |
| |
Sigma Pharmaceuticals (metformin) |
| |
Sovereign Medical (tolbutamide) |
| |
Strides Pharma (metformin) |
| |
Sun Pharmaceuticals (sitagliptin) |
| |
Takeda (alogliptin, metformin) |
| |
Thame Laboratories (metformin, sitagliptin) |
| |
Tillomed Laboratories (metformin) |
| |
Wockhardt (metformin) |
| |
Zentiva (gliclazide, metformin, sitagliptin) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health - Northern Ireland |
| |
Diabetes UK Cymru |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Cochrane Metabolic & Endocrine Disorders Group |
| |
Genomics England |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health Research |
| |
The Society for Research in Rehabilitation |
| |
Wellcome Trust |